MT Højgaard Holding A/S
On 23 November 2020, MT Højgaard Holding A/S announced that a share buy-back programme of an aggregated price of up to DKK 15,000,000 was launched with the purpose to meet obligations arising from the company’s share-based incentive programme.
The share buy-back programme is executed pursuant to the so-called "Safe Harbour" provisions in Regulation (EU) No. 596/2014 of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016. The programme will end no later than on 30 September 2021.
The following transactions have been executed from 8 February to 12 February 2021:
Number of shares | Average purchase price (DKK) | Transaction value (DKK) | |
Accumulated, last announcement | 27,620 | 165.71 | 4,576,887 |
1 February 2021 2 February 2021 3 February 2021 4 February 2021 5 February 2021 | 600 500 500 500 600 | 177.88 178.80 177.29 176.78 177.13 | 106,728 89,400 88,645 88,390 106,278 |
Accumulated under the programme | 30,320 | 5,056,328 |
A detailed overview of transactions executed during the period 8 February to 12 February 2021 is attached to this announcement.
Following the above transactions, MT Højgaard Holding A/S owns a total of 30,320 treasury shares, corresponding to 0.389% of the company’s total share capital.
Contact: CFO Martin Stig Solberg may be contacted by phone on +45 2270 9365
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Rovsing A/S18.9.2025 11:58:00 CEST | Press release
Completion of share issue
Ålandsbanken18.9.2025 11:30:00 CEST | Press release
Ålandsbanken Abp announces a consent solicitation for its up to SEK 150,000,000 Tier 2 Notes due December 2041 and up to SEK 200,000,000 Tier 2 Notes due March 2043 and initiates procedures in writing
Novo Nordisk A/S18.9.2025 10:45:34 CEST | Press release
Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by 23% compared to dulaglutide in the first head-to-head real-world study
Glice AG18.9.2025 10:41:41 CEST | Press release
Europe's Leading Research Institute Confirms Breakthrough: Swiss Company Glice Develops Synthetic Ice with Real-Ice Glide
Sparinvest SICAV18.9.2025 10:40:53 CEST | Pressemeddelelse
Sparinvest SICAV suspenderer handel med afdeling
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom